MD Anderson Cancer: Statins May Improve Survival for Triple-Negative Breast Cancer Patients
August 04, 2021
August 04, 2021
HOUSTON, Texas, Aug. 4 (TNSJou) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Aug. 3, 2021:
A study led by researchers from The University of Texas MD Anderson Cancer Center found a significant association between cholesterol-lowering drugs commonly known as statins and survival rates of triple-negative breast cancer patients. Since statins are low in cost, easy to access and produce minimal side effects, this could have an importan . . .
A study led by researchers from The University of Texas MD Anderson Cancer Center found a significant association between cholesterol-lowering drugs commonly known as statins and survival rates of triple-negative breast cancer patients. Since statins are low in cost, easy to access and produce minimal side effects, this could have an importan . . .